Product pipeline

Developing novel therapeutics that modulate protein homeostasis

Our product pipeline focuses on the discovery and development of novel therapeutics to control or balance the Proteostasis Network (PN) in the treatment of cystic fibrosis, neurodegenerative diseases, and orphan diseases. Additionally, our ongoing collaboration with other leading biotech companies and academic groups is yielding promising new agents targeting the PN.

Cystic Fibrosis Pipeline